Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Jackson CE, Fischer RE, Hsu AP, Anderson SM, Choi Y, Wang J, Dale JK, Fleisher TA, Middelton LA, Sneller MC, Lenardo MJ, Straus SE, Puck JM.

Am J Hum Genet. 1999 Apr;64(4):1002-14.

2.

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE.

Blood. 1997 Feb 15;89(4):1341-8.

3.

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rösen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J, Fischer RE, Jackson CM, Lin AY, Bäumler C, Siegert E, Marx A, Vaishnaw AK, Grodzicky T, Fleisher TA, Lenardo MJ.

Blood. 2001 Jul 1;98(1):194-200.

4.

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

Aspinall AI, Pinto A, Auer IA, Bridges P, Luider J, Dimnik L, Patel KD, Jorgenson K, Woodman RC.

Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):227-38.

PMID:
10575548
5.

[The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death].

Seegers D, Peña AS, Bouma G.

Ned Tijdschr Geneeskd. 2004 Feb 21;148(8):371-6. Review. Dutch.

PMID:
15032090
6.

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.

Bleesing JJ, Brown MR, Straus SE, Dale JK, Siegel RM, Johnson M, Lenardo MJ, Puck JM, Fleisher TA.

Blood. 2001 Oct 15;98(8):2466-73.

7.

A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.

Fleisher TA, Straus SE, Bleesing JJ.

Curr Allergy Asthma Rep. 2001 Nov;1(6):534-40. Review.

PMID:
11895618
8.

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM.

Cell. 1995 Jun 16;81(6):935-46.

9.

Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.

Choi Y, Ramnath VR, Eaton AS, Chen A, Simon-Stoos KL, Kleiner DE, Erikson J, Puck JM.

Clin Immunol. 1999 Oct;93(1):34-45.

PMID:
10497009
10.

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.

Rieux-Laucat F, Blachère S, Danielan S, De Villartay JP, Oleastro M, Solary E, Bader-Meunier B, Arkwright P, Pondaré C, Bernaudin F, Chapel H, Nielsen S, Berrah M, Fischer A, Le Deist F.

Blood. 1999 Oct 15;94(8):2575-82.

11.
12.

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.

Del-Rey M, Ruiz-Contreras J, Bosque A, Calleja S, Gomez-Rial J, Roldan E, Morales P, Serrano A, Anel A, Paz-Artal E, Allende LM.

Blood. 2006 Aug 15;108(4):1306-12.

13.

Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.

Ströbel P, Nanan R, Gattenlöhner S, Müller-Deubert S, Müller-Hermelink HK, Kreth HW, Marx A.

Am J Surg Pathol. 1999 Jul;23(7):829-37.

PMID:
10403307
14.

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?

van der Burg M, de Groot R, Comans-Bitter WM, den Hollander JC, Hooijkaas H, Neijens HJ, Berger RM, Oranje AP, Langerak AW, van Dongen JJ.

Pediatr Res. 2000 Mar;47(3):336-43.

PMID:
10709732
15.

Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis.

Kanegane H, Vilela MM, Wang Y, Futatani T, Matsukura H, Miyawaki T.

Pediatr Nephrol. 2003 May;18(5):454-6.

PMID:
12736807
16.

Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).

Arkwright PD, Rieux-Laucat F, Le Deist F, Stevens RF, Angus B, Cant AJ.

Clin Exp Immunol. 2000 Aug;121(2):353-7.

17.

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W.

Ann Intern Med. 1999 Apr 6;130(7):591-601. Review.

PMID:
10189330
18.

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.

Infante AJ, Britton HA, DeNapoli T, Middelton LA, Lenardo MJ, Jackson CE, Wang J, Fleisher T, Straus SE, Puck JM.

J Pediatr. 1998 Nov;133(5):629-33.

PMID:
9821419
19.

Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.

Poppema S, Maggio E, van den Berg A.

Leuk Lymphoma. 2004 Mar;45(3):423-31. Review.

PMID:
15160902
20.

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

Holzelova E, Vonarbourg C, Stolzenberg MC, Arkwright PD, Selz F, Prieur AM, Blanche S, Bartunkova J, Vilmer E, Fischer A, Le Deist F, Rieux-Laucat F.

N Engl J Med. 2004 Sep 30;351(14):1409-18.

Items per page

Supplemental Content

Support Center